|
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Vaccinia virus infections are of concern as the current smallpox vaccine uses this live virus to inoculate persons against a potential bioterror smallpox attack.Use of the vaccine is contraindicated in persons who are...
|
|
|
$37 million to extend regional biodefense and emerging infectious diseases research
-- The National Institutes of Health (NIH) has extended funding for the Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases (MRCE), anchored at Washington University in St.Louis. The center received a...
Washington University in St. Louis:
Jun 24 2009 9:33PM
Matching: bioterror anthrax smallpox
|
Find similar documents
|
|
|
|
National Jewish Health And Ceragenix Announce Compound Shows Promise For Treating Potentially Lethal Viral Inf
Ceragenix Pharmaceuticals, Inc.('Ceragenix') (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael Howell,...
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
- Ceragenix Pharmaceuticals, Inc.(Ceragenix) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael...
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
DENVER - (BUSINESS WIRE) - Ceragenix Pharmaceuticals, Inc.('Ceragenix' ) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y....
|
|
|
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Inf
Ceragenix Pharmaceuticals, Inc.(Ceragenix) (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at National Jewish Health, led by Dr.Donald Y. Leung and Dr. Michael...
|
|
|
Universal Detection Technology Applies for CAGE and NSN Codes for Its Biological Detection Equipment
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism...
|
|
|
Universal Detection Technology Applies For CAGE And NSN Codes For Its Biological Detection Equipment
Universal Detection Technology (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training...
|
|
|
Universal Detection Technology Applies for CAGE and NSN Codes for Its Biological Detection Equipment
Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism...
|
|
|
Proposal to divert BioShield money into flu effort draws fire
The White House asked Congress on Tuesday for authority to spend up to $9 billion more for an H1N1 flu vaccine and other preparations against the novel flu strain that first appeared in April.Of the total, the administration asked...
|
|
|
Washington Post report
The White House asked Congress on Tuesday for authority to spend up to $9 billion more for an H1N1 flu vaccine and other preparations against the novel flu strain that first appeared in April.Of the total, the administration asked...
|
|
|
WMD Panel Criticizes Plan to Fund Flu Vaccine
President Obama's contingency plan to help finance production of a swine flu vaccine with funds set aside to develop defenses against biological attacks would weaken the nation's preparedness for terrorism, the leaders of a bipartisan...
|
|
|
Bipartisan WMD Panel Criticizes Obama Plan to Fund Swine Flu Vaccine
President Obama's contingency plan to help finance production of a swine flu vaccine with funds set aside to develop defenses against biological attacks would weaken the nation's preparedness for terrorism, the leaders of a bipartisan...
|
|
|
La Jolla Institute unlocks mystery of potentially fatal reaction to smallpox vaccine
Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the ...
|
|
|
La Jolla Institute for Allergy and Immunology Researchers Unlock Mystery Of Potentially Fatal Reaction To Smal
Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the ...
|
|
|
Mystery Of Potentially Fatal Reaction To Smallpox Vaccine Unlocked By La Jolla Institute
Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the ...
|
|
|
Unlocking the Mystery of Potentially Fatal Reaction to Smallpox Vaccine
Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the ...
|
|
|
Scientists unlock mystery of potentially fatal reaction to smallpox vaccine
Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to...
|
